Figures from the Medicines and Healthcare products Regulatory Agency show that increasing numbers need medical treatment ...
In a wide-ranging interview, Xavier Becerra, President Biden’s health secretary, defended his tenure and hinted that he might ...
The 15 drugs selected for negotiation are prescribed to 5.3 million Medicare beneficiaries to treat conditions ranging from ...
Wall Street started higher ahead of Trump's inauguration on Monday. Investors expect a flurry of executive orders, including ...
Swings in the bond market recently sent the yield on the 10-year Treasury above 4.80% and its highest level since 2023.
A modern-day renaissance man, jazz trumpeter and opera composer Terence Blanchard is an 8-time Grammy Award-winner whose film ...
Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.
Ozempic and Wegovy, Novo Nordisk’s GLP-1 drugs that treat diabetes and obesity, are on the list. Astellas Pharma’s prostate cancer drug, Xtandi, is also on the list — alongside AstraZeneca’s cancer ...
The list is a first step in negotiations and, given the timing, the details and final pricing will be left to President-elect Donald Trump's administration. (Scripps News) ...
The US plans to slash the price it pays for the Novo Nordisk A/S blockbusters Ozempic and Wegovy, the latest drugs to be ...
The US plans to slash the price it pays for the Novo Nordisk A/S blockbusters Ozempic and Wegovy, the latest drugs to be ...
Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss treatment Wegovy are among the 15 drugs targeted for ...